Massachusetts Eye And Ear Infirmary

Boston, MA Part of Partners Healthcare System Incorporated

UEI
NA7AKMLK2BM1
CAGE
4F602
Primary NAICS
622310 Specialty (except Psychiatric and Substance Abuse) Hospitals
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • Hospital
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
243 Charles St, Boston, MA 02114, USA
Founded
1824
Employees
1K-5K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $52,417
FY2025 $114,398
FY2024 $228,796

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Veterans Affairs $52,417

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
The General Hospital Corporation The project analyzes a novel µOCT/DµOCT device for in vivo visualization and characterization of the olfactory epithelium in the human nose. The analysis will… R01DC023937 $63,597
The Schepens Eye Research Institute. Inc. Dr. Zebardast is a leading expert in glaucoma health disparities and has studied the impact of race and ethnicity on glaucoma diagnosis and clinical care. Dr.… R01EY036222 $98,627
The General Hospital Corporation Statement of Work for the Massachusetts Eye and Ear (MEE) The overall objective of the proposed research is to generate corneal hydration maps using Brillouin… R01EY038655 $43,968
The Schepens Eye Research Institute. Inc. Leo Kim, MD, PhD (Co-Investigator) at Mass Eye and Ear at Harvard Medical School will devote 0.6 calendar months of effort to this project. For this project,… R01EY038687 $44,804
The Children's Hospital Corporation Dr. Bruce Ksander this grant describes a collaborative research project between the three PIs Of this application: Dr. Bruce Ksander at Schepens I Mass Eye &… R01EY025794 $268,059

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Massachusetts Eye and Ear Infirmary, a Harvard Medical School-affiliated tax-exempt nonprofit hospital and research institution headquartered in Boston, Massachusetts, acts as a prime recipient on federal research grants and delivers specialized clinical ophthalmology and otolaryngology services, hearing and vision research, and gene therapy development to the Department of Veterans Affairs, the National Institutes of Health, and the Defense Health Agency.

The institution's federal footprint centers on biomedical research grants rather than service contracts. The Department of Health and Human Services National Institutes of Health accounts for the largest share of awards by volume, with the National Eye Institute and the National Institute on Deafness and Other Communication Disorders each carrying 76 awards across recent years. The Department of Veterans Affairs Veterans Integrated Service Network 1 represents the primary customer for clinical services, holding 16 awards valued at $1.6 million in combined potential value, including a $810.7 thousand definitive contract for ophthalmology physician services running through January 31, 2031, and a $195 thousand contract for ocular re-animation study research awarded July 1, 2026. Award activity has grown modestly year over year—from 16 awards in 2023 to 28 in 2024 and again in 2026. Forty-three awards carrying combined potential value of $195 thousand face ultimate completion within the next twenty-four months, creating recompete exposure.

Massachusetts Eye and Ear's capability portfolio reflects deep translational and clinical research in hearing, balance, vision, and otolaryngology. Recent prime grant work includes a $1.15 million National Institute on Deafness and Other Communication Disorders award (CFDA 93.173) for an IND-enabling study of AAV-mediated TMPRSS3 gene therapy to treat autosomal recessive hearing loss DFNB8, building on the institution's successful OTOF gene therapy clinical trial for congenital deafness. The institution holds $666.010 thousand from the National Institute of Mental Health (CFDA 93.242) to study co-transmission of GABA and glutamate in cortical circuits and the role of neuromodulatory inputs in adult cortical plasticity. A $1.009 million National Institute for Minority Health and Health Disparities award (CFDA 93.307) supports a randomized clinical trial comparing hybrid telemedical visits and in-person visits for managing diabetic retinopathy across four study arms. Additional active grants address cochlear mechanics, glaucoma genetics and risk prediction, retinal degeneration, vestibular implant outcomes, and intraoperative imaging for sarcoma surgery. The institution also serves as a sub-recipient on multisite collaborative grants from Case Western Reserve University, the Children's Hospital Corporation, the University of Iowa, and other academic centers, contributing clinical recruitment, patient assessments, tissue processing, or specialized expertise to grants anchored elsewhere.

Massachusetts Eye and Ear competes predominantly in full-and-open federal grant programs under standard NIH mechanisms (R01, K01, K23, R21, cooperative agreements) rather than set-aside vehicles. The institution holds no identified parent contract vehicles or GWACs. As a subsidiary of Partners Healthcare System Incorporated, it operates within a larger health care network but maintains its own grant authority and direct relationships with federal agencies. Recent activity demonstrates strength in National Eye Institute vision research, NIDCD hearing and vestibular science, National Institute of Neurological Disorders and Stroke neuroscience, and Defense Health Agency clinical and device development work. The combined potential value across all 396 awards in the source data stands at $11.8 million, though obligated dollars total $802.5 million, reflecting the large clinical and research operations sustained by long-standing grants and contracts. The institution's federal customer base spans 41 agencies, with concentration among NIH institutes and VA service networks, and award concentration in medical and surgical instruments, health R&D services, and ophthalmic instruments and supplies.

Quick answers

Is Massachusetts Eye And Ear Infirmary registered in SAM.gov?

Yes. Massachusetts Eye And Ear Infirmary's SAM.gov registration is active through March 24, 2027.

How much has Massachusetts Eye And Ear Infirmary received in federal contracts?

Federal contracts obligated $114,398 to Massachusetts Eye And Ear Infirmary in fiscal year 2025 and $395,611 in fiscal years 2023 through 2027.

How does Massachusetts Eye And Ear Infirmary rank among federal contractors?

Massachusetts Eye And Ear Infirmary ranked #25 in PSC Q511 in FY2025.

What is Massachusetts Eye And Ear Infirmary's most recent federal award?

Massachusetts Eye And Ear Infirmary's most recent federal grant award is CO-transmission of gaba and glutamate in cortical circuits (R01MH143880), from National Institute of Mental Health (NIH), on September 1, 2026.

On GovTribe

See Massachusetts Eye And Ear Infirmary's full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors